{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T04:05:26Z","timestamp":1759032326513},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1990,12,1]],"date-time":"1990-12-01T00:00:00Z","timestamp":660009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular and Chemical Neuropathology"],"published-print":{"date-parts":[[1990,12]]},"DOI":"10.1007\/bf03159925","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T23:25:34Z","timestamp":1250810734000},"page":"225-232","source":"Crossref","is-referenced-by-count":11,"title":["Urinary excretion of metabolites of norepinephrine in Tourette\u2019s syndrome"],"prefix":"10.1007","volume":"13","author":[{"given":"Glen B.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan B.","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF03159925_CR1","first-page":"171","volume-title":"Advances in Neurology, vol. 35","author":"A. Ang","year":"1982","unstructured":"Ang A., Borison R., Dysken M., and Davis J. M. (1982) Reduced excretion of MHPG in Tourette\u2019s Syndrome,Advances in Neurology, vol. 35 (Friedhoff A. H. and Chase T. N., eds.) Raven, NY, pp. 171\u2013175."},{"key":"BF03159925_CR2","doi-asserted-by":"crossref","unstructured":"Baker G. B., Bornstein R. A., Rouget A. C., Ashton S. E., van Muyden J. C., and Coutts R. T. (1990) Phenylethylaminergic mechanisms in attention deficit disorder.Biol. Psychiatry (in press).","DOI":"10.1016\/0006-3223(91)90207-3"},{"key":"BF03159925_CR3","first-page":"141","volume":"54","author":"G. B. Baker","year":"1986","unstructured":"Baker G. B., Coutts R. T., Bornstein R. A., Dewhurst W. G., Douglass A. B., and MacDonald R. N. (1986) A rapid and sensitive gas chromatographic procedure for analysis of 3-methoxy-4-hydroxyphenylethylene glycol in urine.Res. Commun. Chem. Path. Pharmacol. 54 141\u2013144.","journal-title":"Res. Commun. Chem. Path. Pharmacol."},{"key":"BF03159925_CR4","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3109\/00207458808985765","volume":"42","author":"R. A. Bornstein","year":"1988","unstructured":"Bornstein R. A., and Baker G. B. (1988) Neuropsychological correlates of urinary amine metabolites in Tourette\u2019s syndrome.Int. J. Neurosci. 42, 113\u2013120.","journal-title":"Int. J. Neurosci."},{"key":"BF03159925_CR5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0165-1781(90)90097-O","volume":"31","author":"R. A. Bornstein","year":"1990","unstructured":"Bornstein R. A., and Baker G. B. (1990) Urinary amines in Tourette\u2019s syndrome patients with and without phenylethylamine abnormality.Psychiatry Res. 31, 279\u2013286.","journal-title":"Psychiatry Res."},{"key":"BF03159925_CR6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1176\/jnp.2.4.408","volume":"2","author":"R. A. Bornstein","year":"1990","unstructured":"Bornstein R. A., Baker G. B., Carroll A., King G., and Ashton S. (1990) Phenylethylamine metabolism in Tourette\u2019s syndrome.J. Neuropsychiat. Clin. Neurosci. 2, 408\u2013412.","journal-title":"J. Neuropsychiat. Clin. Neurosci."},{"key":"BF03159925_CR7","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.7403874","volume":"209","author":"G. Cassens","year":"1980","unstructured":"Cassens G., Roffman M., Kuruc A., Orsulak P. J., and Schildraut J. J. (1980) Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock.Science 209, 1138\u20131139.","journal-title":"Science"},{"key":"BF03159925_CR8","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/archpsyc.1978.01770260123015","volume":"35","author":"D. J. Cohen","year":"1978","unstructured":"Cohen D. J., Shaywitz B. A., Caparulo B. K., Young J. G., and Bowers M. B. (1978) Chronic multiple tics of Gilles de la Tourette\u2019s disease.Arch. Gen. Psychiat. 35, 245\u2013250.","journal-title":"Arch. Gen. Psychiat."},{"key":"BF03159925_CR9","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0002-7138(09)61046-3","volume":"18","author":"D. J. Cohen","year":"1979","unstructured":"Cohen D. J., Shaywitz B. A., Young J. G., Carbonari C. M., Nathanson J. A., Lieberman D., Bowers M. B., and Maas J. W. (1979) Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette.J. Am. Acad. Child Psychiatry 18, 320\u2013341.","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"BF03159925_CR10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/0364-7722(81)90047-3","volume":"5","author":"R. T. Coutts","year":"1981","unstructured":"Coutts R. T., Baker G. B., LeGatt D. F., McIntosh G. J., Hopkinson G., and Dewhurst W. G. (1981) Screening for amines of psychiatric interest in urine using gas chromatography with electron-capture detection.Progr. Neuropsychopharmacol. 5, 565\u2013568.","journal-title":"Progr. Neuropsychopharmacol."},{"key":"BF03159925_CR11","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0021-9673(01)84617-3","volume":"466","author":"B. A. Davis","year":"1989","unstructured":"Davis B. A. (1989) Biogenic amines and their metabolites in body fluids of normal, psychiatric, and neurological subjects.J. Chromatogr. 466, 89\u2013218.","journal-title":"J. Chromatogr."},{"key":"BF03159925_CR12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1471-4159.1976.tb06986.x","volume":"26","author":"J. A. Kessler","year":"1976","unstructured":"Kessler J. A., Gordon E. K., Reid J. L., and Kopin I. J. (1976) Homovanillic acid and 3-methoxy-4-hydroxyphenylethylene glycol production by the monkey spinal cord.J. Neurochem. 26, 1057\u20131061.","journal-title":"J. Neurochem."},{"key":"BF03159925_CR13","first-page":"185","volume-title":"Advances in Neurology","author":"S. H. Koslow","year":"1982","unstructured":"Koslow S. H., and Cross C. K. (1982) Cerebrospinal fluid monoamine metabolites in Tourette syndrome and their neuroendocrine implications.Advances in Neurology (Friedhoff A. J., and Chase T. N. eds.), Raven, NY, pp. 185\u2013197."},{"key":"BF03159925_CR14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1176\/ajp.134.3.257","volume":"134","author":"C. R. Lake","year":"1977","unstructured":"Lake C. R., Ziegler M. G., Elridge R., and Murphy D. (1977) Catecholamine metabolism in Gilles de la Tourette\u2019s syndrome.Am. J. Psychiatry 134, 257\u2013360.","journal-title":"Am. J. Psychiatry"},{"key":"BF03159925_CR15","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0002-7138(09)61504-1","volume":"22","author":"J. F. Leckman","year":"1983","unstructured":"Leckman J. F., Detlor J., Harcherik D. F., Young J. G., Anderson G. M., Shaywitz B. A., and Cohen D. J. (1983) Acute and chronic clonidine treatment in Tourette\u2019s syndrome: A preliminary report on clinical response and effect on plasma and urinary catecholamine metabolites, growth hormone, and blood pressure.J. Am. Acad. Child Psychiatry 22, 433\u2013440.","journal-title":"J. Am. Acad. Child Psychiatry"},{"key":"BF03159925_CR16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/0024-3205(80)90606-2","volume":"26","author":"J. F. Leckman","year":"1980","unstructured":"Leckman J. F., Maas J. W., Redmond E. J., and Heninger G. R. (1980) Effects of oral clonidine on plasma 3-methoxy-4-hydroxyphenylethyleneglycol (MHPG) in man: Preliminary report.Life Sci. 26, 1047\u20131061.","journal-title":"Life Sci."},{"key":"BF03159925_CR17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1126\/science.472724","volume":"205","author":"J. W. Maas","year":"1979","unstructured":"Maas J. W., Hattox S. E., Greene N. M., and Landis D. H. (1979) 3-Methoxy-4-hydroxyphenylethyleneglycol production by human brain in vivo.Science 205, 1025\u20131027.","journal-title":"Science"},{"key":"BF03159925_CR18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01248767","volume":"39","author":"E. Markianos","year":"1976","unstructured":"Markianos E., and Beckmann H. (1976) Diurnal changes in dopamine \u03b2-hydroxylase, homovanillic acid, and 3-methoxy-4-hydroxyphenylglycol in serum of man.J. Neural Transm. 39, 79\u201393.","journal-title":"J. Neural Transm."},{"key":"BF03159925_CR19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.154.2.147","volume":"154","author":"M. M. Robertson","year":"1989","unstructured":"Robertson M. M. (1989) The Gilles de la Tourette syndrome: the current status.Br. J. Psychiatry 154, 147\u2013169.","journal-title":"Br. J. Psychiatry"},{"key":"BF03159925_CR20","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1001\/archpsyc.1988.01800330081010","volume":"45","author":"A. Roy","year":"1988","unstructured":"Roy A., Pickar D., DeJong J., Karoum F., and Linnoila M. (1988) Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine.Arch. Gen. Psychiatry 45, 849\u2013857.","journal-title":"Arch. Gen. Psychiatry"},{"key":"BF03159925_CR21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/978-1-4612-4602-2_34","volume-title":"Trace Amines: Comparative and Clinical Neurobiology","author":"M. Sandler","year":"1988","unstructured":"Sandler M., Hale A. S., Hannah P., and Bridges P. K. (1988) The tyramine conjugation test in unipolar and bipolar depressed patients: utility as a predictor of treatment response.Trace Amines: Comparative and Clinical Neurobiology (Boulton A. A., Juorio A. V., and Downer R. G. H., eds.), Humana Press, Clifton, NJ, pp. 369\u2013377."},{"key":"BF03159925_CR22","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1001\/archneur.1984.04050150060018","volume":"41","author":"A. K. Shapiro","year":"1984","unstructured":"Shapiro A. K., Baron M., Shapiro E. S., and Levitt M. (1984) Enzyme activity in Tourette\u2019s syndrome.Arch. Neurol. 41, 282\u2013285.","journal-title":"Arch. Neurol."},{"key":"BF03159925_CR23","volume-title":"Gilles de la Tourette Syndrome","author":"A. K. Shapiro","year":"1988","unstructured":"Shapiro A. K., Shapiro E. S., Young J. G., and Feinber T. E. (1988)Gilles de la Tourette Syndrome, 2nd Ed., Raven, NY.","edition":"2nd Ed."},{"key":"BF03159925_CR24","first-page":"1771","volume-title":"Advances in Neurology, vol. 35","author":"H. S. Singer","year":"1982","unstructured":"Singer H. S., Trine T. E., Butler I. J., Zaczek R., and Coyle J. T. (1982) Clinical symptomatology, CSF neurotransmitter metabolites and serum haloperidol levels in Tourette syndrome,Advances in Neurology, vol. 35 (Friedhoff A. J., and Chase T. N., eds.), Raven, NY, pp. 1771\u20131783."},{"key":"BF03159925_CR25","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/S0140-6736(78)90212-X","volume":"i","author":"D. Sweeney","year":"1978","unstructured":"Sweeney D., Pickar D., Redmond D. E., and Maas J. (1978) Noradrenergic and dopaminergic mechanisms in Gilles de la Tourette\u2019s syndrome.Lancet,i, 872.","journal-title":"Lancet"},{"key":"BF03159925_CR26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/archpsyc.1985.01790260045005","volume":"42","author":"A. J. Zametkin","year":"1985","unstructured":"Zametkin A. J., Karoum F., Linnoila M., Rapoport J. L., Brown G. L., Chuang T. W., and Wyatt R. J. (1985) Stimulants, urinary catecholamines, and indoleamines in hyperactivity. A comparison of methylphenidate and dextroamphetamine.Arch. Gen. Psychiatry 42, 251\u2013255.","journal-title":"Arch. Gen. Psychiatry"}],"container-title":["Molecular and Chemical Neuropathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03159925.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03159925\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03159925","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T03:25:09Z","timestamp":1558495509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03159925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1990,12]]}},"alternative-id":["BF03159925"],"URL":"https:\/\/doi.org\/10.1007\/bf03159925","relation":{},"ISSN":["1044-7393"],"issn-type":[{"value":"1044-7393","type":"print"}],"subject":[],"published":{"date-parts":[[1990,12]]}}}